Alan Furlan

Title: Alan Furlan: Innovator in Digital Polymerase Chain Reaction Technologies

Introduction

Alan Furlan is a notable inventor based in Zug, Switzerland. He has made significant contributions to the field of molecular biology, particularly in the area of digital polymerase chain reaction (dPCR). With a total of six patents to his name, Furlan's work has advanced the accuracy and efficiency of nucleic acid quantification.

Latest Patents

Furlan's latest patents include a method for reducing quantification errors caused by reaction volume deviations in digital polymerase chain reaction. This innovative method addresses the challenges of quantification errors in dPCR, enhancing the reliability of results. Another significant patent involves methods for determining the amount of a nucleic acid of interest in an unprocessed sample by analyzing a processed sample and a reference sample using dPCR.

Career Highlights

Throughout his career, Alan Furlan has worked with prominent companies in the biotechnology sector. He has been associated with Roche Molecular Systems, Inc. and Roche Diagnostics GmbH, where he has contributed to the development of cutting-edge technologies in molecular diagnostics.

Collaborations

Furlan has collaborated with esteemed colleagues in his field, including Joachim Wietzorrek and Michael Zeder. These partnerships have fostered innovation and have been instrumental in advancing research in digital polymerase chain reaction technologies.

Conclusion

Alan Furlan's contributions to the field of molecular biology through his patents and collaborations highlight his role as a leading innovator in digital polymerase chain reaction technologies. His work continues to impact the accuracy of nucleic acid quantification, paving the way for advancements in molecular diagnostics.